Compare Wegovy and Mounjaro Starter Protocols Side-by-Side
Wegovy or Mounjaro for Weight Loss: Understanding Your Starter Dose Options
When beginning either Wegovy or Mounjaro for weight loss, understanding the starter dose approach is crucial for treatment success. Wegovy (semaglutide) begins with a 0.25mg weekly injection for the first four weeks, designed to help your body gradually adjust to this GLP-1 receptor agonist. This gentle introduction minimises potential side effects whilst allowing you to gauge your initial response. Mounjaro (tirzepatide) takes a different approach, starting at 2.5mg weekly for four weeks before escalating, reflecting its dual GIP and GLP-1 receptor mechanism.
The choice between Wegovy or Mounjaro for weight loss starter doses often comes down to individual tolerance and medical history. Wegovy's lower initial dose may suit those sensitive to new medications, whilst Mounjaro's dual-hormone approach offers a different pathway to appetite control. Both treatments require careful dose escalation over 16-20 weeks respectively, and skipping doses isn't recommended for safety reasons. Your prescriber will consider factors including your BMI, previous medication responses, and weight-related health conditions when recommending which starter dose protocol suits you best.
Starter Dose Pricing: Wegovy vs Mounjaro Investment Comparison
EverydayMeds offers transparent pricing for both Wegovy or Mounjaro for weight loss starter doses, helping you budget for your treatment journey. Wegovy 0.25mg starter pens cost £79.99 (with FIRST40 discount applied at checkout for new customers), whilst Mounjaro 2.5mg starter doses are £89.99. For those preferring bundled convenience, our Intro Duo combines Wegovy 0.25mg and 0.5mg doses for £169.99, covering your first eight weeks seamlessly. These prices include full clinical assessment, prescriber review, and next-day cold-chain delivery to ensure optimal medication integrity.
Both prescription-only medicines represent significant investments in your health, with starter doses forming just the beginning of a comprehensive weight management programme. Returning customers benefit from code DOSE25 at checkout, maintaining affordability throughout dose escalation phases. The Gentle Start Trio (£269.99) provides extended 0.25mg dosing for those requiring slower titration, whilst similar flexibility exists for Mounjaro protocols. Remember that these treatments work alongside dietary changes and exercise, making them part of a broader lifestyle investment rather than standalone solutions.
Clinical Evidence: How Wegovy or Mounjaro for Weight Loss Perform in Starter Phases
Clinical trials demonstrate that both treatments show early efficacy signals during starter dose phases, though maximum benefits emerge during maintenance dosing. In the STEP trials (Wilding et al., NEJM, 2021), patients taking Wegovy experienced initial appetite changes within the first month of 0.25mg dosing. Similarly, SURMOUNT trials for Mounjaro showed meaningful appetite reduction beginning with 2.5mg starter doses.
The gradual dose escalation protocols for both Wegovy or Mounjaro for weight loss exist for important safety reasons, allowing your body to adapt to hormonal changes progressively. Early trial discontinuation rates were lowest among patients who completed full titration schedules, emphasising the importance of patience during starter phases. Neither treatment should be expected to produce dramatic weight changes during initial weeks, with significant results typically emerging after reaching therapeutic maintenance doses.
Mechanism Differences: How Wegovy vs Mounjaro Work During Initial Dosing
Wegovy functions as a GLP-1 receptor agonist, mimicking your body's natural incretin hormone that signals fullness after eating. During the 0.25mg starter phase, patients often notice reduced food cravings and earlier satiety with smaller portions, as the medication begins influencing appetite centres in the brain. This single-hormone approach provides targeted appetite regulation, with effects building gradually as doses increase through the 16-week escalation protocol. The medication also slows gastric emptying, helping you feel satisfied longer after meals whilst supporting better blood sugar control. Wegovy's mechanism becomes more pronounced as doses progress from the starter 0.25mg through to the maintenance 2.4mg weekly injection.
EverydayMeds Ordering Process: Starting Wegovy or Mounjaro for Weight Loss
Beginning either treatment through EverydayMeds involves a streamlined three-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our GPhC-registered prescribers (#9012878) review applications within three working days (24-hour express service available), ensuring thorough evaluation before approving either Wegovy or Mounjaro for weight loss prescriptions. Once approved, starter doses dispatch via next-day cold-chain delivery, maintaining optimal storage temperatures throughout transit. The assessment process considers BMI requirements, existing health conditions, and previous weight management attempts to determine the most suitable treatment option. Payment includes the complete service from clinical review through to doorstep delivery, with no hidden fees or consultation charges beyond the medication cost.
Storage and Practical Considerations for Starter Doses
Both treatments require refrigerated storage at 2-8°C before first use, but Wegovy offers superior travel convenience with six weeks room temperature stability compared to Mounjaro's 21-day limit. This becomes particularly relevant for patients with active lifestyles or frequent travel commitments during the extended dose escalation period. Each FlexTouch pen (Wegovy) or KwikPen (Mounjaro) contains four weekly doses, with clear dosing windows and injection depth control for comfortable self-administration. The starter dose phase allows you to develop confident injection technique before progressing to higher concentrations, building familiarity with pen mechanics and injection site rotation. Both medications use similar injection protocols with pre-filled, disposable pens designed for ease of use, though needle lengths and pen designs differ slightly between manufacturers.
First Month Expectations: What Happens During Wegovy or Mounjaro Starter Phases
During your first month on either Wegovy or Mounjaro for weight loss, realistic expectations centre around appetite changes rather than dramatic weight reduction. Many patients report decreased food cravings and earlier feelings of fullness, particularly noticeable during week two or three of starter dosing. Mild gastrointestinal effects like nausea or reduced appetite are common but typically diminish as your body adjusts to the medication. The starter phase serves as a foundation period, allowing you to establish injection routines and dietary modifications before therapeutic doses take full effect.
Weight changes during starter dose periods vary considerably between individuals, with some patients experiencing 1-2kg reductions whilst others see minimal scale movement initially. This variation is entirely normal and doesn't predict long-term treatment success, as both Wegovy or Mounjaro for weight loss demonstrate their primary efficacy during maintenance dosing phases. Focus during the first month should remain on establishing healthy eating patterns, regular meal timing, and staying hydrated, as these habits become increasingly important as appetite suppression intensifies with higher doses.
Ready to Begin Your Weight Loss Journey: Order Your Starter Dose Today
Both Wegovy and Mounjaro represent proven options for medically-supervised weight management, with starter dose protocols designed for safety and tolerability during treatment initiation. EverydayMeds provides comprehensive support throughout your journey, from initial assessment through ongoing prescription management, ensuring continuity of care as you progress through dose escalations. New customers use code FIRST40 at checkout, whilst returning patients apply DOSE25 for continued value throughout their treatment programme. Our clinical team remains available for guidance on treatment selection, helping you choose between these effective prescription-only medicines based on your individual circumstances. Start your consultation today at https://everydaymeds.co.uk/products/wegovy-0-25mg and take the first step towards sustainable weight management with professional medical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
